CONSULTING AGREEMENTConsulting Agreement • April 30th, 2019 • Enlivex Therapeutics Ltd. • Pharmaceutical preparations
Hadasit Medical Research Services and Development Ltd. (“Hadasit”), whose address, for the purposes hereof, is P.O.Box 12000, Jerusalem 91120;
THIS AGREEMENT is made the 7th of September 2018Agreement • April 30th, 2019 • Enlivex Therapeutics Ltd. • Pharmaceutical preparations
Enlivex Therapeutics, Ltd., a company organized under the laws of Israel, corporate number 51373620, whose address is at Kiriat Hadassa P.O.B 1267 Jerusalem Israel 91129 (the “Employer”);
LICENSE AGREEMENT By and Between Tolarex Ltd. a company duly registered under the laws of Israel (company number 513736264, having its principal place of business at Kiryat Hadassah POB 12000 Jerusalem 91120, Israel (hereinafter, “the Company”) on one...License Agreement • April 30th, 2019 • Enlivex Therapeutics Ltd. • Pharmaceutical preparations
WHEREAS, subject to and in accordance with the terms of this License Agreement Tolaren agrees to grant to the Company an exclusive worldwide, royalty free right and license to use the Licensed Technology for the research, development manufacturing, sale and all other aspects of commercialization of products.
Employment AgreementEmployment Agreement • April 30th, 2019 • Enlivex Therapeutics Ltd. • Pharmaceutical preparations
This personal Employment Agreement (the “Agreement”) is made and entered into as of November 1, 2018 (the “Effective Date”), by and between Enlivex Therapeutics Ltd., registration number 513736264, a company incorporated in the State of Israel, having its offices at Kiryat Hadassah POB 12167 Jerusalem 91120, Israel (the “Company”), and Shmuel Hess, I.D. number 015384431, residing in 8B Peleg St, Nes Ziona, Israel 74040 (the “Employee”).
LICENSE AGREEMENTLicense Agreement • April 30th, 2019 • Enlivex Therapeutics Ltd. • Pharmaceutical preparations
WHEREAS, subject to and in accordance with the terms of this License Agreement the Institutes agree to grant to the Company an exclusive worldwide, royalty free right and license to use the Licensed Technology for the research, development, manufacturing, sale and all other aspects of commercialization of products in the Field.
INDEMNIFICATION AGREEMENTIndemnification Agreement • April 30th, 2019 • Enlivex Therapeutics Ltd. • Pharmaceutical preparations
This Indemnification Agreement (“Indemnification Agreement”) is being entered into by and between ___________ (the “Indemnitee”) and Enlivex Therapeutics Ltd., a company organized under the laws of the state of Israel (the “Company”), effective as of ___________, pursuant to the resolutions of the Board of Directors of the Company (the “Board”), dated ___________, as approved by the Company’s shareholders on ___________.
Employment AgreementEmployment Agreement • April 30th, 2019 • Enlivex Therapeutics Ltd. • Pharmaceutical preparations
Between: Enlivex Therapeutics Ltd., Private Company Registration No. 513736264 Of Hadassah Ein Kerem, Jerusalem 91120 (Hereinafter: the “Company”) The first party;
